在患有重度抑郁症的患者中,作为辅助治疗,重新使用德克斯特罗梅索芬:一种随机的,群体顺序的适应性设计,受控的临床试验协议
Shampa Maji1, Debadatta Mohapatra2, Monalisa Jena1
1Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
BMJ open
|April 30, 2024
概括
这项研究研究了德克斯特罗梅索芬作为主要抑郁障碍 (MDD) 的附加疗法,以改善治疗结果. 该试验评估了与安慰剂相比,当与选择性血清素再吸收抑制剂 (SSRI) 结合使用时的疗效和安全性.
科学领域:
- 精神病学是一个精神病学.
- 临床药理学 临床药理学
- 神经科学是一个神经科学.
背景情况:
- 目前用于重大抑郁症 (MDD) 的抗抑郁药疗法面临诸多挑战,包括治疗延迟,有效性有限和药物不良反应.
- 补充疗法是一个潜在的策略,可以提高MDD患者的治疗结果.
- 选择性血清素再吸收抑制剂 (SSRI) 是一种常见的第一线治疗方法,但许多患者无法实现完全缓解.
研究的目的:
- 评估德克斯特罗梅索芬作为SSRI的附加疗法在被诊断为MDD的患者中的疗效和安全性.
- 为了比较德克斯特罗梅索芬加SSRI与安慰剂加SSRI对抑郁症症状严重性的影响.
- 评估二次结果,包括治疗反应,缓解率和神经营养因子的变化.
主要方法:
- 一个随机的,双盲的,安慰剂控制的,组序列设计的临床试验.
- 患有MDD的患者将被随机分配1:1接受德克斯特罗梅索芬 (30毫克每天一次) 或安慰剂,除了他们正在进行的8周的SSRI治疗外.
- 主要结局:蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 评分的变化. 二级结局包括响应率,缓解率,临床全球印象 (CGI),血清BDNF和不良事件.
主要成果:
- 数据分析正在等待8周治疗期和结果评估的完成.
- 对所有主要和次要结局进行治疗意向分析.
- 结果将提供关于德克斯特罗梅索芬作为MDD辅助治疗的疗效和安全性概况的见解.
结论:
- 这项研究旨在确定添加德克斯特罗梅索芬在治疗严重抑郁症时是否比安慰剂具有显著的益处.
- 这些发现可能会支持MDD患者的新疗法选择,MDD患者对单独的SSRI反应不足.
- 该试验遵守道德准则,确保参与者的安全和数据完整性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
01:16Crossover Experiments
2.8K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.8K
01:25Antidepressant Drugs: Overview
459
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
459
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43